InformedDNA Nabs $4.5M Investment | GenomeWeb

NEW YORK (GenomeWeb) – Genetics services firm InformedDNA today said that it has reached a $4.5 million funding agreement with Blue Cross Blue Shield of Massachusetts' wholly owned subsidiary Zaffre Investments.

InformedDNA will use the funds to expand its use of information technology in order to improve the efficiency and capacity of its genetics benefits utilization management capabilities. The company added that the investment also will go toward the management of its rapid growth.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.